BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 30501643)

  • 1. Integrated proteotranscriptomics of breast cancer reveals globally increased protein-mRNA concordance associated with subtypes and survival.
    Tang W; Zhou M; Dorsey TH; Prieto DA; Wang XW; Ruppin E; Veenstra TD; Ambs S
    Genome Med; 2018 Dec; 10(1):94. PubMed ID: 30501643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomic analysis of breast tumors confirms the mRNA intrinsic molecular subtypes using different classifiers: a large-scale analysis of fresh frozen tissue samples.
    Waldemarson S; Kurbasic E; Krogh M; Cifani P; Berggård T; Borg Å; James P
    Breast Cancer Res; 2016 Jun; 18(1):69. PubMed ID: 27357824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteome Profiling Outperforms Transcriptome Profiling for Coexpression Based Gene Function Prediction.
    Wang J; Ma Z; Carr SA; Mertins P; Zhang H; Zhang Z; Chan DW; Ellis MJ; Townsend RR; Smith RD; McDermott JE; Chen X; Paulovich AG; Boja ES; Mesri M; Kinsinger CR; Rodriguez H; Rodland KD; Liebler DC; Zhang B
    Mol Cell Proteomics; 2017 Jan; 16(1):121-134. PubMed ID: 27836980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptomic and Protein Expression Analysis Reveals Clinicopathological Significance of Bloom Syndrome Helicase (BLM) in Breast Cancer.
    Arora A; Abdel-Fatah TM; Agarwal D; Doherty R; Moseley PM; Aleskandarany MA; Green AR; Ball G; Alshareeda AT; Rakha EA; Chan SY; Ellis IO; Madhusudan S
    Mol Cancer Ther; 2015 Apr; 14(4):1057-65. PubMed ID: 25673821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome-wide analysis of alternative transcripts in human breast cancer.
    Wen J; Toomer KH; Chen Z; Cai X
    Breast Cancer Res Treat; 2015 Jun; 151(2):295-307. PubMed ID: 25913416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colorectal Cancer Cell Line Proteomes Are Representative of Primary Tumors and Predict Drug Sensitivity.
    Wang J; Mouradov D; Wang X; Jorissen RN; Chambers MC; Zimmerman LJ; Vasaikar S; Love CG; Li S; Lowes K; Leuchowius KJ; Jousset H; Weinstock J; Yau C; Mariadason J; Shi Z; Ban Y; Chen X; Coffey RJC; Slebos RJC; Burgess AW; Liebler DC; Zhang B; Sieber OM
    Gastroenterology; 2017 Oct; 153(4):1082-1095. PubMed ID: 28625833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Proteomics of Breast Cancer Reveals a Novel Layer of Breast Cancer Classification.
    Yanovich G; Agmon H; Harel M; Sonnenblick A; Peretz T; Geiger T
    Cancer Res; 2018 Oct; 78(20):6001-6010. PubMed ID: 30154156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Semaphorin-plexin signalling genes associated with human breast tumourigenesis.
    Gabrovska PN; Smith RA; Tiang T; Weinstein SR; Haupt LM; Griffiths LR
    Gene; 2011 Dec; 489(2):63-9. PubMed ID: 21925246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A favorable role of prolactin in human breast cancer reveals novel pathway-based gene signatures indicative of tumor differentiation and favorable patient outcome.
    Hachim IY; Shams A; Lebrun JJ; Ali S
    Hum Pathol; 2016 Jul; 53():142-52. PubMed ID: 26980025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preclinical evaluation of cyclin dependent kinase 11 and casein kinase 2 survival kinases as RNA interference targets for triple negative breast cancer therapy.
    Kren BT; Unger GM; Abedin MJ; Vogel RI; Henzler CM; Ahmed K; Trembley JH
    Breast Cancer Res; 2015; 17():19. PubMed ID: 25837326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coupling proteomics and transcriptomics in the quest of subtype-specific proteins in breast cancer.
    Pavlou MP; Dimitromanolakis A; Diamandis EP
    Proteomics; 2013 Apr; 13(7):1083-95. PubMed ID: 23386393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of the miRNA-mRNA-lncRNA networks in ER+ and ER- breast cancer cell lines.
    Wu Q; Guo L; Jiang F; Li L; Li Z; Chen F
    J Cell Mol Med; 2015 Dec; 19(12):2874-87. PubMed ID: 26416600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteome profiling of breast cancer biopsies reveals a wound healing signature of cancer-associated fibroblasts.
    Groessl M; Slany A; Bileck A; Gloessmann K; Kreutz D; Jaeger W; Pfeiler G; Gerner C
    J Proteome Res; 2014 Nov; 13(11):4773-82. PubMed ID: 25238572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein profiling of human breast tumor cells identifies novel biomarkers associated with molecular subtypes.
    Gonçalves A; Charafe-Jauffret E; Bertucci F; Audebert S; Toiron Y; Esterni B; Monville F; Tarpin C; Jacquemier J; Houvenaeghel G; Chabannon C; Extra JM; Viens P; Borg JP; Birnbaum D
    Mol Cell Proteomics; 2008 Aug; 7(8):1420-33. PubMed ID: 18426791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Label-free proteomic analysis of breast cancer molecular subtypes.
    Panis C; Pizzatti L; Herrera AC; Corrêa S; Binato R; Abdelhay E
    J Proteome Res; 2014 Nov; 13(11):4752-72. PubMed ID: 25221861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multipronged quantitative proteomics reveals serum proteome alterations in breast cancer intrinsic subtypes.
    Gajbhiye A; Dabhi R; Taunk K; Jagadeeshaprasad MG; RoyChoudhury S; Mane A; Bayatigeri S; Chaudhury K; Santra MK; Rapole S
    J Proteomics; 2017 Jun; 163():1-13. PubMed ID: 28495502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteomic maps of breast cancer subtypes.
    Tyanova S; Albrechtsen R; Kronqvist P; Cox J; Mann M; Geiger T
    Nat Commun; 2016 Jan; 7():10259. PubMed ID: 26725330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effective personalized therapy for breast cancer based on predictions of cell signaling pathway activation from gene expression analysis.
    Jhan JR; Andrechek ER
    Oncogene; 2017 Jun; 36(25):3553-3561. PubMed ID: 28135251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrated quantitative proteomic and transcriptomic analysis of lung tumor and control tissue: a lung cancer showcase.
    Tenzer S; Leidinger P; Backes C; Huwer H; Hildebrandt A; Lenhof HP; Wesse T; Franke A; Meese E; Keller A
    Oncotarget; 2016 Mar; 7(12):14857-70. PubMed ID: 26930711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In situ proteomic analysis of human breast cancer epithelial cells using laser capture microdissection: annotation by protein set enrichment analysis and gene ontology.
    Cha S; Imielinski MB; Rejtar T; Richardson EA; Thakur D; Sgroi DC; Karger BL
    Mol Cell Proteomics; 2010 Nov; 9(11):2529-44. PubMed ID: 20739354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.